Peter Mac’s excellence in cell and tissue manufacture led to the commercialisation and expansion of this business – Cell Therapies – as a manufacturer of cellular therapeutics.

In the VCCC building, Cell Therapies now operates the leading facility of its kind in Australia and the Asia-Pacific region.

Recent breakthroughs in gene therapy, immunotherapy, stem cell therapy and tissue regeneration have made Cell Therapies an internationally important business. It ensures that new therapies developed overseas can reach Australian patients and that cellular therapies developed by breakthrough Australian research can be produced to GMP grade quality and reach global markets.

Cell Therapies manufactures human cells as therapeutic agents. There are two broad categories of product:

Autologous: using the patient’s own cells, manipulated and returned to them.
Allogeneic: using a donor’s cells, banked, manipulated and distributed to (potentially) many patients.